World’s first study to prove myopia prevention in children by low-concentration atropine drops
Pharma | News | 0 Comment | 14 Mar, 2023
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...Read more
GHIT Fund invests ¥ 260 M for new malaria drug development by Japanese firms
Pharma | News | 0 Comment | 13 Mar, 2023
The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 2...Read more
Elevating Life science industry standards through the implementation of quality practices
Pharma | Analysis | 0 Comment | 10 Mar, 2023
Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...Read more
Australia's Starpharma names Justin Cahill as Chief Financial Officer and Company secretary
Pharma | News | 0 Comment | 10 Mar, 2023
Australian firm Starpharma Holdings has announced the appointment of Justin Cahill as Chief Financial Officer (CFO)...Read more
Japanese firm Sumitomo invests in radiopharmaceutical startup Alpha Fusion
Pharma | News | 0 Comment | 09 Mar, 2023
Japan-based Sumitomo Heavy Industries (SHI) has announced the decision to invest in Alpha Fusion Inc. (AF), a developer ...Read more
China's Biocytogen partners with Janssen for discovery of new antibody-based drugs
Pharma | News | 0 Comment | 09 Mar, 2023
China-based Biocytogen Pharmaceuticals has announced the signing of a non-exclusive license agreement with Janssen Biote...Read more
Japan's Teijin Pharma inks $230 M deal with Novartis for kidney diseases treatment
Pharma | News | 0 Comment | 08 Mar, 2023
Teijin Pharma, based in Japan, has entered into an exclusive global license agreement with Swiss firm Novartis t...Read more
Kyorin and Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries
Pharma | News | 0 Comment | 07 Mar, 2023
Kyorin Pharmaceutical, a subsidiary of Kyorin Holdings, Inc. and Sumitomo Pharma, in Japan, have entered into a license ...Read more
Pharma | Analysis | By Sanjiv Das | 0 Comment | 06 Mar, 2023
The word layoff is accustomed to us and many companies across the globe take part in this exercise. Excuses like global ...Read more
Biogen terminates multiple sclerosis (MS) pact with Eisai in Japan
Pharma | News | 0 Comment | 03 Mar, 2023
Biogen Japan and Eisai have announced the termination of the co-promotion agreement that has been in place since January...Read more
CPHI & PMEC China 2023 to attract over 55,000 visitors on 19-21 June
Pharma | News | 0 Comment | 02 Mar, 2023
In 2023, CPHI & PMEC China will be held in 19-21 June 2023 at SNIEC (Shanghai New International Expo Centre), Shangh...Read more
Deprecated Yen attracts renewed international interest in Japanese pharma
Pharma | News | 0 Comment | 01 Mar, 2023
CPHI Japan 2023 opens in April (19-21) as the country undergoes a huge resurgence in international trade, with West...Read more
Korea's GC Biopharma buys rare disease pipeline in haematology from Catalyst Biosciences
Pharma | News | 0 Comment | 28 Feb, 2023
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has signed an Asset Purchase Agreement wi...Read more
Korea's diabetes drug Envlo to enter $1.54 B market in Brazil and Mexico
Pharma | News | 0 Comment | 01 Mar, 2023
South Korean firm Daewoong Pharmaceutical has announced the launching of their national new drug #36, 'Envlo (ingredient...Read more
Taiwan approves Ono Pharma's non-small cell lung cancer drug with chemotherapy
Pharma | News | 0 Comment | 24 Feb, 2023
Japanese firm Ono Pharmaceutical has received the approval of Opdivo (nivolumab) Intravenous Infusion, a human anti-hu...Read more
South Australian Government takes new initiatives to develop biomanufacturing sector
Pharma | News | 0 Comment | 22 Feb, 2023
Biomanufacturing sector will be given a boost by the South Australian Government’s announcement of new initiatives...Read more
Japanese pharma firm Eisai dissolves joint venture with Italy's Bracco Imaging
Pharma | News | 0 Comment | 21 Feb, 2023
Bracco Imaging S.p.A. (Headquartered in Milan, Italy) and Japan based pharmaceutical firm Eisai Co. have announced that ...Read more
Capricor Therapeutics inks $100 M deal with Nippon Shinyaku for DMD treatment in Japan
Pharma | News | 0 Comment | 20 Feb, 2023
US-based biotech firm Capricor Therapeutics has entered into a partnership with Nippon Shinyaku Co., a Japanese pharmace...Read more